Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Dr. Subramanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Infectious Disease, 1997 - 2000
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1994 - 1997
University of Michigan Medical SchoolClass of 1994
Certifications & Licensure
CA State Medical License 2013 - 2027
MD State Medical License 1997 - 2013
OH State Medical License 1996 - 1998
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Publications & Presentations
PubMed
- Single-Cell and Plasma Proteomics Do Not Differentiate Patients With and Without SARS-CoV-2 Antigenemia in Convalescence in a Cohort of 100 Patients.Shaun Pienkos, Zoe Swank, Rebecca E Hamlin, Mallika Rao, Phillip Grant
Open Forum Infectious Diseases. 2025-09-01 - A Novel Intersection: Cytomegalovirus Gastritis Following Cemiplimab and Talimogene Laherparepvec in a Patient With Advanced Cutaneous Squamous Cell Carcinoma.Goar Egoryan, Alex Zimmet, Mingwei Yu, Joseph Pozdol, Aruna Subramanian
Clinical Case Reports. 2024-12-01 - 19 citationsSex differences and immune correlates of Long Covid development, symptom persistence, and resolution.Rebecca E Hamlin, Shaun M Pienkos, Leslie Chan, Mikayla A Stabile, Kassandra Pinedo
Science Translational Medicine. 2024-11-13
Journal Articles
- Impact of Pre-Transplant Donor BK Viruria in Kidney Transplant RecipientsAruna K Subramanian, Amy E Gallo, Jane C Tan, Gregory A Storch, Jason Kurzer, Benjamin A Pinsky, Waldo Concepcion, Susanna K Tan, Diane Alonso, The Journal of Infectious Diseases
Other
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19Aruna Subramanian, MD, The New England Journal of Medicine
https://www.doximity.com/articles/5d801831-c3b0-4ab4-9bf0-19bd673040b5
UpToDate, Wolters Kluwer Health - 2011-06-15
Authored Content
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19May 2020
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19May 2020
Press Mentions
What Does COVID-19 Do to Your Brain?February 7th, 2022- Antibodies in Blood Soon After COVID-19 Onset May Predict SeverityJanuary 18th, 2022
- Promising COVID Treatments Could Reach San Francisco Pharmacies by JanuaryDecember 3rd, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
